Menu

Natasha Leskovsek

Of Counsel

I’ve taken my clinical and consulting experience for pharma and biotech companies on regulatory issues and brought them to Cooley’s clients.

nleskovsek@cooley.com

full contact info

Natasha Leskovsek advises pharmaceutical, biotechnology, medical device and food/dietary supplement industry clients on US Food and Drug Administration regulatory and clinical development matters. She also conducts regulatory diligence on behalf of entities investing in FDA-regulated companies.

Download full bio 

Experience

  • Poseida Therapeutics Enters Strategic Collaboration and License Agreement With Roche 

  • Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals 

  • Cytokinetics – $450 Million Convertible Senior Notes Offering 

  • Sixth Street Invests in Blueprint Medicines 

  • Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion 

  • View all

Practices & Industries
Passions

    Providing practical compliance solutions at the intersection of science and regulation

Education

  • Georgetown University Law Center
    JD, 1996

  • University of Maryland, College Park
    MBA, 1991

  • University of Maryland, College Park
    MPM, 1991

  • University of Maryland, Baltimore
    BSN, 1989

Admissions & Credentials

District of Columbia

Maryland

Media & Insight
Memberships

  • American Health Lawyers Association

  • Food and Drug Law Institute

Contact

nleskovsek@cooley.com

+1 202 728 7131

Locations